Yinglu Liu

Metabolic reprogramming for CAR-T cell therapy: advances and perspectives

Chimeric antigen receptor T cell (CAR-T) therapy has redefined the therapeutic landscape of hematological malignancies, yet its efficacy in solid tumors remains constrained by rapid functional attrition. Metabolic fitness serves as the primary arbiter of CAR-T cell fate, orchestr...